AdvaMed Medical Imaging
Shaping the Future of the Medical Imaging Sector
AdvaMed’s newest division — Medical Imaging – represents the world’s largest, leading companies that are providing healthcare professionals with the ability to screen, diagnose, treat, and monitor patients by providing accurate, detailed images.
Advancements in medical imaging technologies have rapidly progressed over the last decade, playing a pivotal role in patient care, as well as medical research and discovery. From AI-based innovations, data-driven insights, and digital health tech, these tools lead to better individual patient outcomes and benefits to the entire healthcare system.
Scott Whitaker, President and CEO of AdvaMed
“From AI to digital health tech, the advocacy issues faced by our imaging companies will only increase. No trade organization is better prepared than AdvaMed to take those challenges head on so that our members can continue focusing on what they do best—meeting the needs of the patients they serve.”
Peter J. Arduini, President and CEO of GE HealthCare and Chair of the AdvaMed Board of Directors
“We are in a new era in which medical imaging is ubiquitous—an era in which providers rely on imaging for screening, diagnosis, monitoring, and therapy delivery, as well as medical research and discovery.”
AdvaMed represents a wide range of companies manufacturing medical imaging equipment, radiopharmaceuticals, contrast media, and focused ultrasound devices.
- Imaging makes up approximately 80% of AI technology cleared by FDA.
- In the U.S., a medical image is taken every 3 seconds.
- The global market for medical imaging was valued at $32.3 billion US dollars in 2022.
- An estimated 3.6 billion diagnostic X-ray examinations are taken each year.